Case Studies & Decision Scenarios
See how governed decisions change what move forward.
Real drug development decisions systems involve uncertainty, competing hypothesis, and high cost. Our case studies shows how OmicsX decision Systems bring clarity before capital compounds risk.
featured Scenario
TSDS | Target & Molecule
Choosing Among Four Molecules Against One Target
A company has four molecules with activity against the same target. Each looked promising, but evidence quality, selectivity, and development risk varied significantly.
- Decision Point
Which molecule deserves progression towards IND-enabling development ?
- System Applied
TSDS Target-Scoped Decision System
- Governance Focus
Molecule comparison, evidence boundaries, risk and feasibility assessment.
- Output
Proceed / Pause / Stop map with required proof for each molecule
Read the Scenario
Explore Scenarios By Decision Area
TARGET & MOLECULE
Choosing Among Four Molecules Against One Target
How a target-scoped decision system identified the molecule with the strongest evidence and the lowest development risk.
View Scenario
TARGET & MOLECULE
Target Permission for a Difficult Oncology Target
A target looked promising but had unresolved biology and weak translational evidence. We applied TSDS to determine permission.
View Scenario
MODALITY & PROGRAM
When Degradation Looks Real but Mechanism Is Not Proven
apparently strong degradation data failed mechanism truth and specificity tests. Outcome : Program stopped early.
View Scenario
MODALITY & PROGRAM
When the Delivered Payload Is Not the Active Species Assumed
Post-release competence and intracellular engagement were weaker than expected. We paused and re-designed the construct.
View Scenario
VENDOR & EXECUTION
Vendor Output Is Complete but Not Decision-Useful
CRO outputs were extensive but not comparable or decision-ready. We corrected interfaces and re-established evidence value.
View Scenario
BD & CAPITAL
BD-Sourced Molecule : Diligence or Decline?
An external asset had a strong narrative but uneven evidence. We ran a diligence decision and defined go / no-go boundaries.
View Scenario
What Our Case Studies Show - And What Stays Inside the System
Public case studies show:
- Decision context and business question
- Risk pattern and uncertainty
- OmicsX system applied
- Governance output type and impact
Client systems contains:
- Evidence boundaries and thresholds
- Gate logic and permission rules
- Artifact structures and templates
- Decision records and audit trail